associated nuclear factors, have also been implicated in tissue-specific gene regulation, as some of them are cell Locus control regions (LCRs) are thought to provide type-specific in their activity (Faisst and Meyer, 1992 ).
a dominant tissue-specific open chromatin domain
The role of these elements is thought to be the modulation that allows for proper gene regulation by enhancers/ of RNA polymerase activity (reviewed in Singer and Berg, silencers and their associated transcription factors.
1991). Their action is thought to be subsequent to LCRExpression of the T-cell receptor alpha (TCRα) gene mediated chromatin opening, which allows nuclear factor is limited to T cells and its locus exists in different access to their DNA-binding sites. chromatin configurations in expressing and nonPre-rearranged T-cell receptor alpha (TCRα) transgenes expressing cell types. Here we show that eight DNase under endogenous controls are expressed only in T cell-I-hypersensitive sites in the TCRα locus comprise an bearing tissues, such as thymus and spleen, but not in LCR that confers T-cell compartment-specific expresother organs, such as the liver and heart (Diaz et al., sion upon a linked heterologous transgene. Removal 1994) . Moreover, the endogenous TCRα locus exists in of the three 5Ј-most hypersensitive sites of this LCR, differential chromatin configurations in expressing and containing TCRα enhancers/silencers, abolishes tissuenon-expressing tissues (Hong et al., 1997) . We aim to find differential chromatin structure and results in transthe in vivo sequence requirements for the determination of gene expression in all tissues examined. The remaining this T cell-specific chromatin structure and gene expression five DNase I-hypersensitive sites therefore constitute of the TCRα locus. a novel control element possessing a widely active
In T-cell lines, eight DNase I-hypersensitive sites (HS) chromatin-opening function that allows for ubiquitous have been identified in the 3Ј region of the TCRα locus. expression of a linked transgene in all transgenic HS1 maps to the well characterized TCRα enhancer founder mice. Furthermore, these data show that cis- (Winoto and Baltimore, 1989a ; reviewed in Leiden, 1993) . acting elements without inherent LCR activity can HS2-6 lie 3Ј of HS1 in the locus while HS7 and 8 are 5Ј dominantly modulate chromatin structure to determine to HS1 (Diaz et al., 1994) . HS1 and HS6 are the tissue-specific gene expression in vivo. Boehmer, 1990; Diaz et al., 1994) . This indicates that these three HS alone do not comprise an LCR. Inclusion A locus control region (LCR) is a DNA regulatory element of HS2-6 in such a TCR transgene results in high-level, that imparts position-independent, high-level, copy position-independent, copy number-dependent and T cellnumber-dependent, tissue-specific expression of a linked specific expression (Diaz et al., 1994) . Therefore, HS1-8 transgene in chromatin (Grosveld et al., 1987; reviewed appears to constitute a T cell-specific LCR. in Orkin, 1990; Felsenfeld, 1992) . Without an LCR,
Introduction
Here we report that a 6 kb subfragment of this LCR transgene expression is subject to 'position effect variegacontains a chromatin-opening activity that is not restricted tion' and can be absent if the transgene is integrated into to T cells. A reporter transgene linked to this fragment is inactive chromatin (reviewed in Palmiter and Brinster, expressed in all transgenic founder mice, though not in a 1986). It is widely believed that LCRs function by strictly copy number-dependent manner. Unexpectedly, providing an open chromatin environment, which is necesexpression is seen in all tissues examined. Therefore, sary for proper expression of a linked transgene independthis fragment constitutes a novel non-tissue-restricted ently of the state of surrounding chromatin at the locus chromatin-opening element with a subset of LCR-like of integration (Festenstein et al., 1996; Milot et al., 1996) .
properties. The remaining 3 kb of immediate upstream This chromatin-opening ability is thought to be inherently sequence in the LCR contain previously characterized tissue-specific in nature. It has been observed that the activity of an LCR is restricted to the tissues in which its enhancer/silencer elements (Winoto and Baltimore, 1989a,b) and several HS without inherent LCR activity. introns, promoter and enhancer (Greaves et al., 1989) . Extensive previous work has established that this β-globin We further show that these cis-acting elements, when included in the above transgene, alter the chromatin fragment is only expressed sporadically and at varying levels in erythroid cells (Chada et al., 1985; Townes et al. , configuration of neighboring sequences and restrict transgene activity to T cell-bearing tissues. Thus, these 1985; Grosveld et al., 1987; Greaves et al., 1989) . Addition of the β-globin LCR leads to its high-level, erythroidsequences provide tissue specificity to the downstream chromatin-opening activity. These data support a novel specific expression (Grosveld et al., 1987) , while addition of the human CD2 LCR to this fragment results in highrole for non-LCR transcriptional regulatory elements as modulators of chromatin structure in the determination of level reporter β-globin expression only in T cells (Greaves et al., 1989) . These results indicate that this is a suitable tissue-specific gene expression in vivo.
reporter system for our LCR studies. We linked the β-globin fragment to either the 9 kb region of the TCRα
Results
locus containing all eight HS identified in the locus (β:1-8) or to the 6 kb subregion containing HS2, 3, 4, 5
A transgenic reporter system for TCRα LCR analysis and 6 (β:2-6). Transgenic mice were prepared using these constructs, and multiple independent founder lines were To define and characterize the TCRα LCR further, two transgenic constructs were made (Figure 1 ). Both include analyzed for each. Transgene transcription was measured by RNase protection. A 220 base RNA probe was used a 4.9 kb BglII fragment of the human β-globin locus as a 'reporter gene'. This fragment contains the β-globin exons, to detect human β-globin mRNA. As a loading control, a 135 base RNA probe to γ-actin was added to the hybridization reactions (Enoch et al., 1986) . RNase protection of thymus and spleen RNA from β:1-8 transgenic mice showed that all eight independent lines of varying copy number efficiently expressed the human β-globin mRNA (five lines shown in Figure 2A and B). PhosphorImager analysis showed that expression, in general, trends upwards with increasing copy number ( Figure 2C ). Small deviations from copy-related expression seen in this construct (e.g. line 48 spleen) may be partially explained by the heterologous nature of the reporter gene. Such minor deviations populations and this could contribute to these deviations. The β-globin signal was normalized to the actin signal and given an arbitrary number. The β-globin expression under the control of HS1-8 is HS1-8 is T cell restricted while HS2-6 is ubiquitously active high. In the lowest copy line (#15), β-globin expression, per copy, is Ͼ200% of the endogenous TCRα expression
To examine the distribution of human β-globin mRNA driven by the two transgenes, total RNA was prepared (data not shown). These data demonstrate that the HS1-8 sequences, linked to a heterologous transgene and from various transgenic mouse tissues. High-level mRNA production by the β:1-8 construct was restricted to thymus present in multicopy transgene concatemers, retain most of their LCR properties. They will therefore be referred and spleen, two organs with significant numbers of T cells ( Figure 4A and B). This transgene's expression was very to hereinafter as the TCRα LCR.
Similarly to the β:1-8 transgene, the β:2-6 transgene low to absent in non-lymphoid tissues. Surprisingly, the β:2-6 transgene was expressed efficiently in all tissues was expressed in the thymus and spleen of all six independent transgenic lines ( Figure 3A and B). However, several analyzed ( Figure 4C ). Expression was seen in the thymus, heart, spleen, kidney, liver and lung. The same ubiquitous important differences were observed between the two transgenes. The β:2-6 transgene does not maintain the distribution was seen in organs (specifically liver, heart, lung, kidney and thymus) that had been perfused to remove upward trend in expression with increasing copy number seen with β:1-8 in thymus. Splenic expression of this circulating blood (data not shown). Thus, HS2-6 appears to be ubiquitously functional. The expression of the β:2-6 transgene does show a better relationship with copy number than thymic expression in five of six lines (line 7 transgene in non-lymphoid organs, in general, tends upward with increasing copy number ( Figure 5A and B). gives higher than predicted splenic expression) ( Figure  3C ). It also appears that removal of the HS 7, 8 and 1
However, as in thymus and spleen, it is not absolutely region from the transgene causes a severe reduction in copy-number dependent. This is particularly obvious in thymic expression of the reporter transgene (note the the low-copy lines. These data show that addition of the y-axes of thymus panels in Figures 2C and 3C ). This 3 kb HS7, 8, 1 region appears to inhibit reporter transcripreduction is probably due to the absence of the TCRα tion in non-lymphoid organs, while greatly increasing transcriptional enhancer in β:2-6. This shows that the thymic transgene expression. Thus, these cis-acting eledeleted region is necessary for high-level, copy-related ments restrict the activity of the TCRα LCR, limiting expression in thymus. In contrast to the thymus, the degree high-level transgene expression to T-cell compartments. of splenic expression per copy is more similar for both HS2-6 opens chromatin equivalently in lymphoid β:1-8 and β:2-6 transgenes. Non-T cell expression of and non-lymphoid organs β:2-6 in the spleen might mask the reduction in T-cell Since LCRs are thought to act at the level of chromatin transgene expression observed in the thymus and produce structure, we examined the chromatin configuration of the observed result. As the spleen contains mostly non-T the two β-globin transgenic constructs. The DNase I cells, these results suggest that deletion of HS7, 8 and 1 changes the cell type distribution of transgene expression.
hypersensitivity assay (DHA) was used to probe the chromatin conformation of the transgene loci. We analyzed HS7, 8, 1 region also assumed different chromatin configurations in thymus and liver ( Figure 6B ). HS8 is much different mouse tissues to look for correlation between the chromatin structure and mRNA expression patterns.
stronger in thymus than in liver. This correlates with the higher transgene expression observed in thymus. As in Figure 6A shows a DHA of the β:2-6 transgene locus in thymus (lymphoid) and liver (non-lymphoid). The DNase the endogenous locus, thymic nuclei displayed a strong HS1 on the β:1-8 transgene that mapped to the TCRα I hypersensitivity pattern appears equivalent in both tissues, and indicates a chromatin conformation that leaves enhancer region. Liver nuclei from multiple independent β:1-8 lines showed an HS pair located 3Ј of HS1 that the region broadly accessible to nucleases. Distinct bands in the region of HS5 and HS6 are observed. There are corresponds to HS1Ј. To confirm that HS1 and HS1Ј were indeed different, they were mapped relative to a BglII site additional prominent smears where HS2 and HS3 would be expected. A weak smear is seen in the HS4 region. In in their vicinity ( Figure 7 ). Genomic DNA samples isolated from DNase-treated liver and thymic nuclei were divided one line, the HS4 smear is as strong as the others in both tissues (data not shown). There are additional HS smears into equal fractions. All samples were digested with MfeI restriction enzyme to generate the parent restriction in the β-globin gene itself. The open, and equivalent, chromatin configurations apparent in both tissues are fragment. One fraction from each tissue was then digested further with BglII. By comparing the relative mobility of different from the HS patterns observed in the endogenous locus (Hong et al., 1997) , but correlate with the efficient DNase-generated subfragments with the double restriction enzyme-digested fragment, we show that the HS1Ј pair is expression of the transgene in those organs.
3Ј of the BglII. In contrast, the HS1 cluster in thymus appears to include the BglII site and extend further 5Ј and HS7, 8 and 1 determine tissue-specific chromatin structure slightly 3Ј. These two HS clusters localize similarly in the endogenous TCRα locus (data not shown). A map of Figure 6B shows a DHA performed on a β:1-8 transgenic mouse. The addition to β:2-6 of 3 kb of 5Ј-flanking DNA the locations of HS1 and HS1Ј is shown (Figure 7 ). These data show that a 3 kb region of the TCRα locus containing altered the chromatin configuration formed at the HS2-6 region, making it more similar to the endogenous HS multiple cis-acting elements can modulate the chromatinopening activity of the neighboring HS2-6 region, causing pattern (Hong et al., 1997) . In the TCRα locus, HS6 is much stronger in thymus than in liver. HS2-5, 7 and 8 the region to assume different configurations in thymus and liver. are generally much weaker in both organs than is observed in T-cell lines (Diaz et al., 1994) . The α-enhancerassociated HS1 is very strong in thymus. In liver, and Discussion other non-lymphoid organs, HS1 is replaced by a strong hypersensitive site further 3Ј which we call HS1Ј. HS1
It is important to understand how tissue-specific gene expression is achieved in the context of chromatin. We itself is not detected in these organs. Similarly, in the β:1-8 transgene, DNase sensitivity of the HS2-5 region have developed a transgenic mouse model system for understanding how classical transcriptional control elewas suppressed in both thymus and liver. Thymic nuclei displayed a stronger HS6 than liver nuclei. The added ments and LCRs cooperate in determination of the cell mechanisms governing cell type differentiation in vivo. This information is also crucial to the design of gene therapy strategies.
Differential chromatin structure and gene expression
In contrast to the open state of chromatin at active loci, closed chromatin structure (i.e. not DNase I hypersensitive) is usually observed at silenced gene (and transgene) loci (Grosveld et al., 1987; Felsenfeld, 1992; Elliot et al., 1995; Festenstein et al., 1996; Milot et al., 1996) . In our TCRα LCR model system, interaction of HS7, 8 and 1 sequences with the HS2-6 region does not close the chromatin in non-lymphoid organs but, rather, alters the open state of the chromatin. This change correlates with a dramatic change in the distribution of transgene expression. These data indicate that discrete changes in chromatin structure, rather than complete chromatin closure, can also accomplish gene silencing to achieve tissue-specific transcription. Our recent discovery of the ubiquitously expressed Dad1 gene (Apte et al., 1992; Nakashima et al., 1993) 3 kb 3Ј of the TCRα LCR (Hong et al., 1997) provides a rationale for why HS2-6 interaction with 5Ј cis-acting elements would not completely shut down the LCR.
The alternative 'open' conformation of the LCR in non-T cells may be indicative of a state in which it is able to communicate with the downstream Dad1 gene, but not the upstream TCRα gene. In this model, the Dad1 gene may be dependent on elements of the TCRα LCR for its expression. We currently are testing this possibility.
A model for tissue-specific expression of the TCRα locus in chromatin
The differential patterns of DNase I hypersensitivity in thymus and liver suggest a possible model for how T cell restriction is imposed in the β:1-8 transgene. HS1Ј, formed in liver, could constitute a negative element (for example, a silencer or boundary) that prevents cooperation between the LCR and upstream enhancers/promoters. Boundary elements have been described in both human and chicken globin genes (Chung et al., 1993; Li and Stamatoyannopoulos, 1994) . Silencers have been described in the CD4 gene (Sawada et al., 1994 , Siu et al., 1994 . This negative element would prevent induction of strong hypersensitivity at HS1, 8 and 6 inhibiting transcription in liver (and presumably in other non-T cell-bearing organs). In T cells, the negative element would be overcome by the presence of the nearby TCRα enhancer. The binding of lymphoid-specific proteins to their recognition sites in this region would render the site hypersensitive in lymphoid organs, altering the chromatin structure so as to limit the activity of the negative element. This could be accomplished by the lymphoid-specific protein LEF-1, an DNA complex, could in principle alter chromatin structure (Grosschedl et al., 1994) . Several other studies have documented the ability of transcription factors to effect type-specific expression and chromatin structure of the TCRα locus. Knowledge of the roles of various transcripchanges in local chromatin structure (Stamatoyannopoulos et al., 1995; Boyes and Felsenfeld, 1996) . Furthermore, it tional control elements implicated in this process, and the nature of their cooperation, may reveal the molecular has been proposed that enhancer elements counteract repressive chromatin structures as a component of their action (Jenuwein et al., 1993; Barton and Emerson, 1994; Walters et al., 1996) . Establishment of cooperation between the downstream and upstream elements within the TCRα LCR may render HS6 more sensitive to DNase I and relatively suppress the nuclease sensitivity of the HS2-5 region. In the β:2-6 transgene, the proposed negative element and TCRα enhancer elements are absent, leaving the HS2-6 region free to interact with upstream elements in the human β-globin reporter gene and drive transcription. This is evidenced by the extensive nuclease sensitivity of this construct in both thymus and liver. Differential chromatin structures which exist in thymus and liver at the endogenous TCRα locus are strikingly similar to those formed on the β:1-8 transgene. Therefore, the proposed model applies to endogenous T cell-specific control of TCRα gene expression. This supports an important role for the regulation of differential chromatin structure and LCR activity by other cis-acting elements in the determination of cell type-specific gene expression in vivo. The model gives some non-LCR transcriptional control elements a dual role in determining tissue-specific gene expression as modifiers of both RNA polymerase activity and LCR function. A similar 'dual role' hypothesis has been invoked to explain characteristics of enhancer activity in vitro and in stably transfected cell lines (Jenuwein et al., 1993; Barton and Emerson, 1994; Walters et al., 1996) . indicates MfeI-digested, non-DNase-treated sample. The DNase-treated
The discovery of a ubiquitous chromatin-opening activity samples were divided and treated as described in the text. Restriction is novel. The TCRα LCR HS2-6 region should be a enzymes used in double digestion are indicated. This experiment was run on a 0.6% agarose gel. HS1 and HS1Ј are indicated with arrows.
useful tool for driving expression of genes systemically
The localization of HS1 and HS1Ј clusters (indicated by vertical in transgenic mouse models. This element may also be arrows) relative to restriction sites is shown below.
helpful in the design of vectors for gene therapy applications. It may be possible to use HS2-6 together with particular combinations of other cis-acting elements to and its enhancers are considered to be erythrocyte specific (Behringer et al., 1987; Antoniou et al., 1988) , we (this direct transgene expression to specific tissues. It appears, however, that not all tissue-specific cis-acting elements study) and others (Greaves et al., 1989) have shown that these elements do not drive erythroid-specific expression can dominantly restrict this region's activity. Although human β-globin is erythrocyte specific in its expression, under the influence of heterologous LCRs. It is possible that our chromatin-opening element enables the human β-globin control sequences to use the transcriptional regulatory machinery of the various organs sufficiently to drive RNA polymerase, whereas alone, these elements appear to drive erythroid-specific expression (Chada et al., 1985; Townes et al., 1985) . The HS2-6 element described here has many characteristics of an LCR. It permits efficient transgene expression in all founders and drives quite high levels of expression in some organs that trend upward with increasing copy number. It provides open chromatin for a linked transgene organs in which it is active. This is particularly evident in the thymus of high-copy β:2-6 lines and the nonfactor as well as G-rich sequences (GT boxes) known to lymphoid organs of the low-copy lines. Secondly, complete bind the ubiquitous Sp-1 family proteins. A combination LCRs should function in single copy (Ellis et al., 1996) . of both of these cis-acting elements is essential for the Our only single-copy β:2-6 line gives less expression per activity of HS3, suggesting that the chromatin-opening copy than the multicopy lines, indicating that the HS2-6 activity of the β-globin LCR requires both ubiquitous and region may be functioning as a 'partial LCR' (Ellis et al.,
tissue-specific factors (Philipsen et al., 1993 (Philipsen et al., ). 1996 Milot et al., 1996) . Elements within the β-globin
In the TCRα locus, we show separable elements conreporter gene appear to cooperate somewhat with HS2-6 trolling tissue specificity and chromatin opening. In addito partially restore some degree of copy-related expression tion, we show that non-LCR, TCRα cis-acting elements in non-lymphoid organs. However, copy-related expression are dominant in controlling the chromatin structure, turning in thymus clearly requires the T cell-specific elements the ubiquitously active HS2-6 chromatin-opening region contained in the HS7, 8 and 1 region. We propose that into a T cell-specific LCR. HS6 is the most prominent the HS2-6 region represents a novel element that provides HS in this region. The sequence of the 610 bp PvuIIopen chromatin and linked transgene expression in all SmaI fragment containing HS6 is shown in Figure 8 . This founder mice. This element is a ubiquitously active subunit region contains many G-rich sequences (GT boxes) similar of the TCRα LCR. This activity, in combination with the to those found in the minimal β-globin LCR HS regions. upstream tissue-restrictive elements, comprise, at least in This novel element, in general, or these G-rich motifs multiple copies, a T cell-specific LCR.
specifically, may be an important common component of Perhaps what most distinguishes the HS2-6 element the chromatin-opening activity for the TCRα, β-globin from LCRs is its ubiquitous activity. LCRs have been and perhaps other LCRs. The ubiquitous activity of the described in many tissue-specific gene loci, including TCRα HS2-6 region may be due to the presence of these human β-globin (Grosveld et al., 1987) , chicken macroelements, whose activity would be modulated by the 5Ј phage-specific lysozyme (Bonifer et al., 1994) , human cis-acting elements (HS7, 8, 1 and 1Ј) to enforce T cell CD2 (Greaves et al., 1989) , human growth hormone specificity. Perhaps LCR-integral, tissue-specific elements (Jones et al., 1995) , human adenosine deaminase (Aronow play analogous roles within other LCRs. Alternatively, the et al., 1992) and the immunoglobulin heavy chain locus wide activity of this chromatin-opening region may reflect (Madisen and Groudine, 1994) . These LCRs have all the presence of other uncharacterized elements that are been shown to drive tissue-specific expression of linked not present in tissue-specific LCRs. Further mutational transgenes in mice and/or cell lines. Furthermore, these analysis and identification of proteins mediating the HS2-LCRs contain within them elements with enhancer activity 6 region activity and comparison with other systems (Tuan et al., 1989; Lake et al., 1990; Aronow et al., 1992;  should lead to a better general understanding of the Bonifer et al., 1994; Madisen and Groudine, 1994 ; Jones molecular basis for LCR function. et al., 1995) . In contrast, HS2-6 appears to be devoid of classical transcriptional enhancer activity (Diaz et al., 
Materials and methods

1994).
The most extensively characterized LCR is that for
Transgenic mice
β-globin (reviewed in Dillon and Grosveld, 1993; Engel, DNA fragments for microinjection were purified by double gel purification on low-melting point agarose (Seaplaque-FMC) followed by 1993; Orkin, 1995; Martin et al., 1996) . It consists of four digestion with β-agarase (New England Biolabs). DNA was microinjected HS located 6-22 kb upstream of the fetal ε-globin gene.
into the pronucleus of (C57BlϫCBA)F1 fertilized mouse eggs, and LCR activity has been mapped to three 200-300 bp core transferred into pseudo-pregnant CD1 foster mothers. et al., 1986) . Resulting RNA probes were acrylamide Philipsen,S. and Grosveld,F. (1996) A dominant chromatin-opening gel-purified prior to hybridization. activity in 5Ј hypersensitive site 3 of the human β-globin locus control region. EMBO J., 15, 562-568.
DNase hypersensitivity assays
Engel,J.D. (1993) Developmental regulation of human beta-globin gene Nuclei from liver (Wu, 1989) and thymus (Enver et al., 1985) were transcription: a switch of loyalties? Trends Genet., 9, 304-309. prepared then resuspended in DNase digestion buffer (Siebenlist et al., Enoch,T., Zinn,K. and Maniatis,T. (1986) Activation of the human beta-1984) at 10 8 nuclei/ml. Nuclei were digested for 10 min on ice then interferon gene requires an interferon-inducible factor. Mol. Cell. stopped with 1/10 volume 5% SDS/100 mM EDTA. Genomic DNA was Biol., 6, 801-810. 
